International Flavors & Fragrances Inc. (IFF) Stock Analysis
By Nova Skye | AltStation.io | Updated February 07, 2026
Company Overview
International Flavors & Fragrances Inc. (IFF) develops and sells products primarily in the food, beverage, health, scent, and pharmaceutical sectors. Their offerings include natural-based food ingredients like plant proteins and flavorings, fragrance compounds, and ingredients for health and personal care products. Their diverse client base includes food manufacturers, beverage companies, and pharmaceutical firms across the globe. Headquartered in New York, IFF operates in a wide variety of markets, leveraging its extensive portfolio to meet customer needs.
IFF is a market leader in the specialty chemicals segment, with a robust position across multiple categories. Their extensive research and development capabilities give them an edge, allowing for innovative product formulations. However, they face competition from companies like Firmenich, Givaudan, and Symrise, which are also strong players in the flavor and fragrance sector. Market dynamics include rising demand for natural ingredients and plant-based products, driving both opportunities and pressures for pricing and margins.
Currently, IFF is in a phase of strategic transformation following its merger with DuPont’s Nutrition & Biosciences unit in early 2021. This merger aimed to expand their market reach and product offerings, indicating a strong pivot towards health and wellness sectors. While the company has reported challenges, such as supply chain pressures and fluctuating input costs, it remains focused on sustainable growth and enhancing operational efficiencies. As of now, IFF is working to integrate its expanded portfolio and innovate within the growing health and wellness markets, which could position it well for future success.
52-Week Price Performance Analysis
Recent News and Developments
(IFF) stock in the past week:
International Flavors & Fragrances (IFF) has seen a notable increase in analyst optimism recently, contributing to positive stock movement. Barclays raised its price target on IFF shares to $78 from $75, maintaining an “overweight” rating. Similarly, Bank of America increased its target to $88, and Citigroup adjusted its target to $83. This positive sentiment from analysts helped fuel a significant rally in IFF’s stock price.
IFF’s stock demonstrated considerable movement in the past week, with a notable surge on February 4, 2026. Shares climbed by 5.56% as investors positioned themselves ahead of the company’s upcoming fourth-quarter earnings report. However, the stock saw a slight decline on February 5, 2026, as some investors engaged in profit-taking following the sharp rally. As of February 6, 2026, IFF’s stock closed at $74.82, reflecting a market capitalization of $18.81 billion.
Market Sentiment and Analyst Recommendations
Earnings and Financial Data
Frequently Asked Questions
Related Stock Reports
